Derivatization of genotoxic nitroaromatic impurities for trace analysis by LC-MS

被引:8
|
作者
Wu, Xinghua [1 ]
Zhu, Li [1 ]
Visky, Dora [1 ]
Xie, Ruimin [1 ]
Shao, Shan [1 ]
Liang, Xiaozhong [1 ]
机构
[1] Celgene Corp, Analyt Dev Dept, Summit, NJ 07901 USA
关键词
D O I
10.1039/c4ay00916a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Trace level analysis of genotoxic impurities requires highly sensitive analytical methodologies and poses a tremendous challenge for the pharmaceutical industry. Nitroaromatic compounds, among the genotoxic structural alerts, are widely used as starting materials or intermediates for the synthesis of active pharmaceutical ingredients (APIs). If their genotoxicities are confirmed, the nitroaromatic impurities need to be controlled under the Threshold of Toxicological Concern (TTC) level. In general, HPLC-UV methodology is not suitable due to the inadequate sensitivity of the UV detection. Many nitroaromatic compounds used in the pharmaceutical industry are non-volatile, and thus the application of GC is limited. If used directly, LC-MS methodology is less useful to neutral nitroaromatic compounds that lack ionization efficiency. In this article, the authors report a new methodology to detect and quantify trace nitroaromatic compounds by LC-MS after chemical derivatization, where the nitroaromatic compounds are reduced to the corresponding ionizable aromatic amines. It is the authors' hope to provide a general methodology for detecting and quantifying nitroaromatics at trace levels. The reported method is validated for sensitivity, linearity, precision and accuracy. This methodology has been successfully applied to one of Celgene's projects and the detailed case study is provided in this article.
引用
收藏
页码:7277 / 7284
页数:8
相关论文
共 50 条
  • [21] A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis
    A. M. van Wijk
    B. Beerman
    H. A. G. Niederländer
    A. H. G. Siebum
    G. J. de Jong
    Analytical and Bioanalytical Chemistry, 2011, 400 : 1375 - 1385
  • [22] A Validated LC-MS/MS Method for Determination at Trace Level of Nitrosamine Impurities in Doxofylline API
    Remidicherla, Swetha Sri
    Chakravarthi, Guntupalli
    Malothu, Narender
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (04) : s1262 - s1270
  • [23] Analysis of impurities in pharmaceuticals by LC-MS with cold electron ionization
    Tsizin, Svetlana
    Fialkov, Alexander B.
    Amirav, Aviv
    JOURNAL OF MASS SPECTROMETRY, 2020, 55 (10):
  • [24] LC-MS/MS and in silico analysis of pharmaceutical impurities in a combination drug for hypertension
    Kim, Jong-Sil
    Jung, Seo-Hyeon
    Bae, Woo-Hyun
    Lee, Kye-Wan
    Lee, Yong-Moon
    SEPARATION SCIENCE PLUS, 2022, 5 (10) : 546 - 558
  • [26] Direct comparison of derivatization strategies for LC-MS/MS analysis of N-glycans
    Zhou, Shiyue
    Veillon, Lucas
    Dong, Xue
    Huang, Yifan
    Mechref, Yehia
    ANALYST, 2017, 142 (23) : 4446 - 4455
  • [27] Quantitative analysis of methylmalonic acid in human plasma by LC-MS/ MS after derivatization
    Shen, Danhong
    Chen, Wei
    Liu, Jindi
    Liu, Yanhua
    Shi, Hongjun
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1248
  • [28] A Simple and Sensitive LC-MS/MS Method for Determination and Quantification of Potential Genotoxic Impurities in the Vismodegib Active Pharmaceutical Ingredient
    Rao, Rayala Rama
    Kumar, Gundapaneni Ravi
    Vardhan, Vadde Megha
    Boddu, Veeraswami
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44B) : 88 - 102
  • [29] A simple and sensitive LC-MS/MS method for determination and quantification of potential genotoxic impurities in the ceritinib active pharmaceutical ingredient
    Antolcic, Mia
    Runje, Mislav
    Galic, Nives
    ANALYTICAL METHODS, 2020, 12 (25) : 3290 - 3295
  • [30] Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
    Szekely, Gy.
    Henriques, B.
    Gil, M.
    Ramos, A.
    Alvarez, C.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 251 - 258